A number of states have proposed bills that take on the rising cost of drug pricing. And, unlike in the past, many are on track to becoming law.
It’s gotten to the point where Wall Street is starting to take notice.
“These laws are now at the ‘annoyance’ level, rather than material commercial impact but presumably once a coalition gels at state level and reaps political rewards, more is possible,” Bernstein analyst Ronny Gal wrote.
Here are the states that have either passed bills, or are in the process of passing legislation that could increase transparency around drug prices.